Pharus Diagnostics, an innovative healthcare company based in Hsinchu, Taiwan, announced an exclusive global license agreement with the City of Hope, one of the largest cancer research and treatment organizations in the United States
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global pharmaceutical company, has announced financial results for the third quarter ended December 31, 2023.
Lupine Limited (Lupin), a global pharmaceutical company, announced the launch of Ganirelix Acetate Injection, 250 mcg / 0.5 mL, single-dose prefilled syringe, approved by the United States Food and Drug Administration (FDA).
The Central Drugs Standard Control Organization (CDSCO) has released the final version of its regulatory guidelines for sampling medicines, cosmetics and medical devices by central drug inspectors to simplify and streamline sampling procedures
Cipla said it has partnered with CSIR-Central Drug Research Institute to foster a novel ophthalmic detailing for contagious keratitis mutually. The coordinated effort expects to use the consolidated mastery and assets of the two associations to...
Biogen Inc. announced the European Commission (EC) has authorized Skyclarys (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. Skyclarys is the first treatment approved within the...
Numab Therapeutics AG, an organization creating multi-explicit antibody-based immunotherapies for irritation and cancer disease, and Osaka-settled Research and development situated drug organization, Ono Pharma, both mutually declared a worldwide...
Boehringer Ingelheim's (BI) said its diabetes drug Jardiance (empagliflozin) 10mg measurements structure has now been approved by the Focal Medications Standard Control Association of India for the therapy of ongoing kidney illness (CKD), as an...
Curasight A/S, a clinical development company based in Copenhagen, Denmark, announced that it is accelerating and expanding its clinical treatment strategy by adding new Phase 1/2a trials covering five cancer symptoms
DelSiTech Ltd., a pharmaceutical development and supply company, and Tolmar International Ltd., a fully integrated pharmaceutical company, have strengthened their partnership by signing a global licensing and development agreement following Tolmar's
, CDSCO.jpg)
